Načítá se...
Effects of Glycyrrhetic Acid on Human Chronic Myelogenous Leukemia Cells
OBJECTIVES: Chronic myelogenous leukemia (CML) is a type of blood cancer that is initially treated with imatinib (first Abl kinase inhibitor). However, some patients with CML develop imatinib resistance. Several new generation drugs have been developed, but do not overcome this problem. Glycyrrhetic...
Uloženo v:
| Vydáno v: | Turk J Pharm Sci |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Galenos Publishing
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227864/ https://ncbi.nlm.nih.gov/pubmed/32454760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjps.galenos.2018.49389 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|